Mansour Alfayez

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Cancer Discovery · 2019 · 474 citations

Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis

Systematic review or meta-analysis · American Journal of Kidney Diseases · 2013 · 155 citations